Global Human Immunoglobulin for Intravenous Injection Market Growth 2025-2031

December 2025 | 111 pages | ID: G58A2BC22AD0EN
LP Information

Abstracts

The global Human Immunoglobulin for Intravenous Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Human immunoglobulin for intravenous injection is a blood product used for intravenous injection, and its effects can last from 2 weeks to 3 months.

United States market for Human Immunoglobulin for Intravenous Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Human Immunoglobulin for Intravenous Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Human Immunoglobulin for Intravenous Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Human Immunoglobulin for Intravenous Injection players cover Tiantan Biological, Taibang Biological, Shanghai Laishi, Hualan Biological, Zhenghua Shenghua, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Human Immunoglobulin for Intravenous Injection Industry Forecast” looks at past sales and reviews total world Human Immunoglobulin for Intravenous Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Immunoglobulin for Intravenous Injection sales for 2025 through 2031. With Human Immunoglobulin for Intravenous Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Immunoglobulin for Intravenous Injection industry.

This Insight Report provides a comprehensive analysis of the global Human Immunoglobulin for Intravenous Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Immunoglobulin for Intravenous Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Immunoglobulin for Intravenous Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Immunoglobulin for Intravenous Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Immunoglobulin for Intravenous Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Immunoglobulin for Intravenous Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Children
• Adult

Segmentation by Application:

• Disease Prevention
• Treatment
• Diagnosis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Tiantan Biological
• Taibang Biological
• Shanghai Laishi
• Hualan Biological
• Zhenghua Shenghua
• Yuanda shuyang
• Weiguang Biological
• Boya Biological
• Nanyue Biological
• Paisi feike
• Kangbao Biological
• Lvshizi
• Zhongyuan Ruide

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Immunoglobulin for Intravenous Injection market?

What factors are driving Human Immunoglobulin for Intravenous Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Immunoglobulin for Intravenous Injection market opportunities vary by end market size?

How does Human Immunoglobulin for Intravenous Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Immunoglobulin for Intravenous Injection Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Human Immunoglobulin for Intravenous Injection by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Human Immunoglobulin for Intravenous Injection by Country/Region, 2020, 2024 & 2031
2.2 Human Immunoglobulin for Intravenous Injection Segment by Type
  2.2.1 Children
  2.2.2 Adult
2.3 Human Immunoglobulin for Intravenous Injection Sales by Type
  2.3.1 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
  2.3.2 Global Human Immunoglobulin for Intravenous Injection Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Human Immunoglobulin for Intravenous Injection Sale Price by Type (2020-2025)
2.4 Human Immunoglobulin for Intravenous Injection Segment by Application
  2.4.1 Disease Prevention
  2.4.2 Treatment
  2.4.3 Diagnosis
  2.4.4 Other
2.5 Human Immunoglobulin for Intravenous Injection Sales by Application
  2.5.1 Global Human Immunoglobulin for Intravenous Injection Sale Market Share by Application (2020-2025)
  2.5.2 Global Human Immunoglobulin for Intravenous Injection Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Human Immunoglobulin for Intravenous Injection Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Human Immunoglobulin for Intravenous Injection Breakdown Data by Company
  3.1.1 Global Human Immunoglobulin for Intravenous Injection Annual Sales by Company (2020-2025)
  3.1.2 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Company (2020-2025)
3.2 Global Human Immunoglobulin for Intravenous Injection Annual Revenue by Company (2020-2025)
  3.2.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Company (2020-2025)
  3.2.2 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Company (2020-2025)
3.3 Global Human Immunoglobulin for Intravenous Injection Sale Price by Company
3.4 Key Manufacturers Human Immunoglobulin for Intravenous Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Human Immunoglobulin for Intravenous Injection Product Location Distribution
  3.4.2 Players Human Immunoglobulin for Intravenous Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Human Immunoglobulin for Intravenous Injection Market Size by Geographic Region (2020-2025)
  4.1.1 Global Human Immunoglobulin for Intravenous Injection Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Human Immunoglobulin for Intravenous Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Immunoglobulin for Intravenous Injection Market Size by Country/Region (2020-2025)
  4.2.1 Global Human Immunoglobulin for Intravenous Injection Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Human Immunoglobulin for Intravenous Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Immunoglobulin for Intravenous Injection Sales Growth
4.4 APAC Human Immunoglobulin for Intravenous Injection Sales Growth
4.5 Europe Human Immunoglobulin for Intravenous Injection Sales Growth
4.6 Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Growth

5 AMERICAS

5.1 Americas Human Immunoglobulin for Intravenous Injection Sales by Country
  5.1.1 Americas Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025)
  5.1.2 Americas Human Immunoglobulin for Intravenous Injection Revenue by Country (2020-2025)
5.2 Americas Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025)
5.3 Americas Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Immunoglobulin for Intravenous Injection Sales by Region
  6.1.1 APAC Human Immunoglobulin for Intravenous Injection Sales by Region (2020-2025)
  6.1.2 APAC Human Immunoglobulin for Intravenous Injection Revenue by Region (2020-2025)
6.2 APAC Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025)
6.3 APAC Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Human Immunoglobulin for Intravenous Injection by Country
  7.1.1 Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025)
  7.1.2 Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2020-2025)
7.2 Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025)
7.3 Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Immunoglobulin for Intravenous Injection by Country
  8.1.1 Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Immunoglobulin for Intravenous Injection
10.3 Manufacturing Process Analysis of Human Immunoglobulin for Intravenous Injection
10.4 Industry Chain Structure of Human Immunoglobulin for Intravenous Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Human Immunoglobulin for Intravenous Injection Distributors
11.3 Human Immunoglobulin for Intravenous Injection Customer

12 WORLD FORECAST REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION BY GEOGRAPHIC REGION

12.1 Global Human Immunoglobulin for Intravenous Injection Market Size Forecast by Region
  12.1.1 Global Human Immunoglobulin for Intravenous Injection Forecast by Region (2026-2031)
  12.1.2 Global Human Immunoglobulin for Intravenous Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Immunoglobulin for Intravenous Injection Forecast by Type (2026-2031)
12.7 Global Human Immunoglobulin for Intravenous Injection Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Tiantan Biological
  13.1.1 Tiantan Biological Company Information
  13.1.2 Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.1.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Tiantan Biological Main Business Overview
  13.1.5 Tiantan Biological Latest Developments
13.2 Taibang Biological
  13.2.1 Taibang Biological Company Information
  13.2.2 Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.2.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Taibang Biological Main Business Overview
  13.2.5 Taibang Biological Latest Developments
13.3 Shanghai Laishi
  13.3.1 Shanghai Laishi Company Information
  13.3.2 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.3.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Shanghai Laishi Main Business Overview
  13.3.5 Shanghai Laishi Latest Developments
13.4 Hualan Biological
  13.4.1 Hualan Biological Company Information
  13.4.2 Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.4.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hualan Biological Main Business Overview
  13.4.5 Hualan Biological Latest Developments
13.5 Zhenghua Shenghua
  13.5.1 Zhenghua Shenghua Company Information
  13.5.2 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.5.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Zhenghua Shenghua Main Business Overview
  13.5.5 Zhenghua Shenghua Latest Developments
13.6 Yuanda shuyang
  13.6.1 Yuanda shuyang Company Information
  13.6.2 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Yuanda shuyang Main Business Overview
  13.6.5 Yuanda shuyang Latest Developments
13.7 Weiguang Biological
  13.7.1 Weiguang Biological Company Information
  13.7.2 Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.7.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Weiguang Biological Main Business Overview
  13.7.5 Weiguang Biological Latest Developments
13.8 Boya Biological
  13.8.1 Boya Biological Company Information
  13.8.2 Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.8.3 Boya Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Boya Biological Main Business Overview
  13.8.5 Boya Biological Latest Developments
13.9 Nanyue Biological
  13.9.1 Nanyue Biological Company Information
  13.9.2 Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Nanyue Biological Main Business Overview
  13.9.5 Nanyue Biological Latest Developments
13.10 Paisi feike
  13.10.1 Paisi feike Company Information
  13.10.2 Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.10.3 Paisi feike Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Paisi feike Main Business Overview
  13.10.5 Paisi feike Latest Developments
13.11 Kangbao Biological
  13.11.1 Kangbao Biological Company Information
  13.11.2 Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.11.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Kangbao Biological Main Business Overview
  13.11.5 Kangbao Biological Latest Developments
13.12 Lvshizi
  13.12.1 Lvshizi Company Information
  13.12.2 Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.12.3 Lvshizi Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Lvshizi Main Business Overview
  13.12.5 Lvshizi Latest Developments
13.13 Zhongyuan Ruide
  13.13.1 Zhongyuan Ruide Company Information
  13.13.2 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
  13.13.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Zhongyuan Ruide Main Business Overview
  13.13.5 Zhongyuan Ruide Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Human Immunoglobulin for Intravenous Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Immunoglobulin for Intravenous Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Children
Table 4. Major Players of Adult
Table 5. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025) & (K Units)
Table 6. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
Table 7. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Human Immunoglobulin for Intravenous Injection Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Human Immunoglobulin for Intravenous Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Human Immunoglobulin for Intravenous Injection Sale Market Share by Application (2020-2025)
Table 12. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Human Immunoglobulin for Intravenous Injection Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Human Immunoglobulin for Intravenous Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Company (2020-2025)
Table 17. Global Human Immunoglobulin for Intravenous Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Human Immunoglobulin for Intravenous Injection Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Human Immunoglobulin for Intravenous Injection Producing Area Distribution and Sales Area
Table 21. Players Human Immunoglobulin for Intravenous Injection Products Offered
Table 22. Human Immunoglobulin for Intravenous Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Immunoglobulin for Intravenous Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Immunoglobulin for Intravenous Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Immunoglobulin for Intravenous Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Immunoglobulin for Intravenous Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Human Immunoglobulin for Intravenous Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025) & (K Units)
Table 37. Americas Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Human Immunoglobulin for Intravenous Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Human Immunoglobulin for Intravenous Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025) & (K Units)
Table 42. APAC Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025) & (K Units)
Table 46. Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Immunoglobulin for Intravenous Injection
Table 52. Key Market Challenges & Risks of Human Immunoglobulin for Intravenous Injection
Table 53. Key Industry Trends of Human Immunoglobulin for Intravenous Injection
Table 54. Human Immunoglobulin for Intravenous Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Immunoglobulin for Intravenous Injection Distributors List
Table 57. Human Immunoglobulin for Intravenous Injection Customer List
Table 58. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Immunoglobulin for Intravenous Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Human Immunoglobulin for Intravenous Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Immunoglobulin for Intravenous Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Human Immunoglobulin for Intravenous Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Immunoglobulin for Intravenous Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Human Immunoglobulin for Intravenous Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Tiantan Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 74. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Tiantan Biological Main Business
Table 76. Tiantan Biological Latest Developments
Table 77. Taibang Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 79. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Taibang Biological Main Business
Table 81. Taibang Biological Latest Developments
Table 82. Shanghai Laishi Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 84. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Shanghai Laishi Main Business
Table 86. Shanghai Laishi Latest Developments
Table 87. Hualan Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 89. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hualan Biological Main Business
Table 91. Hualan Biological Latest Developments
Table 92. Zhenghua Shenghua Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 94. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Zhenghua Shenghua Main Business
Table 96. Zhenghua Shenghua Latest Developments
Table 97. Yuanda shuyang Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 99. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Yuanda shuyang Main Business
Table 101. Yuanda shuyang Latest Developments
Table 102. Weiguang Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 104. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Weiguang Biological Main Business
Table 106. Weiguang Biological Latest Developments
Table 107. Boya Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 109. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Boya Biological Main Business
Table 111. Boya Biological Latest Developments
Table 112. Nanyue Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 114. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Nanyue Biological Main Business
Table 116. Nanyue Biological Latest Developments
Table 117. Paisi feike Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 119. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Paisi feike Main Business
Table 121. Paisi feike Latest Developments
Table 122. Kangbao Biological Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 124. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Kangbao Biological Main Business
Table 126. Kangbao Biological Latest Developments
Table 127. Lvshizi Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 129. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Lvshizi Main Business
Table 131. Lvshizi Latest Developments
Table 132. Zhongyuan Ruide Basic Information, Human Immunoglobulin for Intravenous Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolios and Specifications
Table 134. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Zhongyuan Ruide Main Business
Table 136. Zhongyuan Ruide Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Human Immunoglobulin for Intravenous Injection
Figure 2. Human Immunoglobulin for Intravenous Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Immunoglobulin for Intravenous Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Immunoglobulin for Intravenous Injection Sales Market Share by Country/Region (2024)
Figure 10. Human Immunoglobulin for Intravenous Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Children
Figure 12. Product Picture of Adult
Figure 13. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type in 2025
Figure 14. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2020-2025)
Figure 15. Human Immunoglobulin for Intravenous Injection Consumed in Disease Prevention
Figure 16. Global Human Immunoglobulin for Intravenous Injection Market: Disease Prevention (2020-2025) & (K Units)
Figure 17. Human Immunoglobulin for Intravenous Injection Consumed in Treatment
Figure 18. Global Human Immunoglobulin for Intravenous Injection Market: Treatment (2020-2025) & (K Units)
Figure 19. Human Immunoglobulin for Intravenous Injection Consumed in Diagnosis
Figure 20. Global Human Immunoglobulin for Intravenous Injection Market: Diagnosis (2020-2025) & (K Units)
Figure 21. Human Immunoglobulin for Intravenous Injection Consumed in Other
Figure 22. Global Human Immunoglobulin for Intravenous Injection Market: Other (2020-2025) & (K Units)
Figure 23. Global Human Immunoglobulin for Intravenous Injection Sale Market Share by Application (2024)
Figure 24. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application in 2025
Figure 25. Human Immunoglobulin for Intravenous Injection Sales by Company in 2025 (K Units)
Figure 26. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Company in 2025
Figure 27. Human Immunoglobulin for Intravenous Injection Revenue by Company in 2025 ($ millions)
Figure 28. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Company in 2025
Figure 29. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Human Immunoglobulin for Intravenous Injection Sales 2020-2025 (K Units)
Figure 32. Americas Human Immunoglobulin for Intravenous Injection Revenue 2020-2025 ($ millions)
Figure 33. APAC Human Immunoglobulin for Intravenous Injection Sales 2020-2025 (K Units)
Figure 34. APAC Human Immunoglobulin for Intravenous Injection Revenue 2020-2025 ($ millions)
Figure 35. Europe Human Immunoglobulin for Intravenous Injection Sales 2020-2025 (K Units)
Figure 36. Europe Human Immunoglobulin for Intravenous Injection Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue 2020-2025 ($ millions)
Figure 39. Americas Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2025
Figure 40. Americas Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2020-2025)
Figure 41. Americas Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
Figure 42. Americas Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2020-2025)
Figure 43. United States Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Human Immunoglobulin for Intravenous Injection Sales Market Share by Region in 2025
Figure 48. APAC Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2020-2025)
Figure 49. APAC Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
Figure 50. APAC Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2020-2025)
Figure 51. China Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. India Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2025
Figure 59. Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2020-2025)
Figure 60. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
Figure 61. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2020-2025)
Figure 62. Germany Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. France Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2020-2025)
Figure 70. Egypt Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Human Immunoglobulin for Intravenous Injection Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Immunoglobulin for Intravenous Injection in 2025
Figure 76. Manufacturing Process Analysis of Human Immunoglobulin for Intravenous Injection
Figure 77. Industry Chain Structure of Human Immunoglobulin for Intravenous Injection
Figure 78. Channels of Distribution
Figure 79. Global Human Immunoglobulin for Intravenous Injection Sales Market Forecast by Region (2026-2031)
Figure 80. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Application (2026-2031)